BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 08/07/1998

FDA Withdraws Approval for Combination Drugs Containing Theophylline, Ephedrine Sulfate, and Hydroxyzine Hydrochloride

The FDA is withdrawing approval for Marax Tablets and Marax Syrup, as well as other related products, due to a lack of substantial evidence showing their effectiveness in treating bronchial asthma.

Source: Federal Register — Food and Drug AdministrationOpen original release →